Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2015, Article ID 176409, 14 pages
Research Article

Bcl-xL Genetic Modification Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cell Transplantation in the Treatment of Heart Infarction

1Department of Cardiovascular Surgery, General Hospital of Shenyang Military Area Command, Shenyang Northern Hospital, Wenhua Road No. 83, Shenhe District, Shenyang 110016, China
2Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi 710032, China

Received 19 August 2014; Revised 4 November 2014; Accepted 11 November 2014

Academic Editor: Sadia Mohsin

Copyright © 2015 Xiaodong Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Figure 1: The surface marker expression of rat bone marrow MSCs.

The expressions of selected surface markers of rat bone marrow MSCs were analyzed by Flowcytometry. Mouse IgG1 was used as an isotype control (A); in rat bone marrow MSCs, CD29, CD90 and CD44 were highly expressed (B–D) while the markers for hematopoietic stem cells, CD34 and CD45, were not expressed (E and F).

  1. Supplementary Materials